<DOC>
	<DOC>NCT00489073</DOC>
	<brief_summary>The primary purpose of this study is to determine if duloxetine reduces pain severity in patients with fibromyalgia.</brief_summary>
	<brief_title>Duloxetine Versus Placebo for Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>You are male or female outpatient at least 18 years of age with fibromyalgia. Females of childbearing potential must test negative on a pregnancy test at visit 1. Serious or unstable cardiovascular, hepatic, renal, respiratory, or hematologic illness, symptomatic peripheral vascular disease, or other medical condition (including unstable hypertension and not clinically euthyroid) or psychological conditions that in the opinion of the investigator would compromise participation or be likely to lead to hospitalization during the course of the study. Abnormal thyroidstimulating hormone concentrations.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>